242 related articles for article (PubMed ID: 28624610)
21. Accelerated antigen presentation and elicitation of humoral response in vivo by FcgammaRIIB- and FcgammaRI/III-mediated immune complex uptake.
Yada A; Ebihara S; Matsumura K; Endo S; Maeda T; Nakamura A; Akiyama K; Aiba S; Takai T
Cell Immunol; 2003 Sep; 225(1):21-32. PubMed ID: 14643301
[TBL] [Abstract][Full Text] [Related]
22. Tissue-Specific Expression of the Low-Affinity IgG Receptor, FcγRIIb, on Human Mast Cells.
Burton OT; Epp A; Fanny ME; Miller SJ; Stranks AJ; Teague JE; Clark RA; van de Rijn M; Oettgen HC
Front Immunol; 2018; 9():1244. PubMed ID: 29928276
[TBL] [Abstract][Full Text] [Related]
23. Rapid desensitization of humanized mice with anti-human FcεRIα monoclonal antibodies.
Khodoun MV; Morris SC; Angerman E; Potter C; Schuman R; Wunderlich M; Maciag JJ; Sullivan Locker KC; Mulloy JC; Herr AB; Finkelman FD
J Allergy Clin Immunol; 2020 Mar; 145(3):907-921.e3. PubMed ID: 31836406
[TBL] [Abstract][Full Text] [Related]
24. Macrophages are the dominant effector cells responsible for IgG-mediated passive systemic anaphylaxis challenged by natural protein antigen in BALB/c and C57BL/6 mice.
Jiao D; Liu Y; Lu X; Liu B; Pan Q; Liu Y; Liu Y; Zhu P; Fu N
Cell Immunol; 2014; 289(1-2):97-105. PubMed ID: 24751884
[TBL] [Abstract][Full Text] [Related]
25. IgE-mediated suppression of primary antibody responses in vivo.
Karlsson MC; Diaz de Ståhl T; Heyman B
Scand J Immunol; 2001 Apr; 53(4):381-5. PubMed ID: 11285118
[TBL] [Abstract][Full Text] [Related]
26. Allergen-specific IgG antibody signaling through FcγRIIb promotes food tolerance.
Burton OT; Tamayo JM; Stranks AJ; Koleoglou KJ; Oettgen HC
J Allergy Clin Immunol; 2018 Jan; 141(1):189-201.e3. PubMed ID: 28479335
[TBL] [Abstract][Full Text] [Related]
27. Development and characterisation of monoclonal antibodies specific for the murine inhibitory FcγRIIB (CD32B).
Williams EL; Tutt AL; French RR; Chan HT; Lau B; Penfold CA; Mockridge CI; Roghanian A; Cox KL; Verbeek JS; Glennie MJ; Cragg MS
Eur J Immunol; 2012 Aug; 42(8):2109-20. PubMed ID: 22760702
[TBL] [Abstract][Full Text] [Related]
28. Fcγ receptor dependency of agonistic CD40 antibody in lymphoma therapy can be overcome through antibody multimerization.
White AL; Dou L; Chan HT; Field VL; Mockridge CI; Moss K; Williams EL; Booth SG; French RR; Potter EA; Butts C; Al-Shamkhani A; Cragg MS; Verbeek JS; Johnson PW; Glennie MJ; Beers SA
J Immunol; 2014 Aug; 193(4):1828-35. PubMed ID: 25024386
[TBL] [Abstract][Full Text] [Related]
29. Hypersensitivity reactions to asparaginase in mice are mediated by anti-asparaginase IgE and IgG and the immunoglobulin receptors FcεRI and FcγRIII.
Rathod S; Ramsey M; Relling MV; Finkelman FD; Fernandez CA
Haematologica; 2019 Feb; 104(2):319-329. PubMed ID: 30237274
[TBL] [Abstract][Full Text] [Related]
30. Cγ1 Deficiency Exacerbates Collagen-Induced Arthritis.
Strait RT; Thornton S; Finkelman FD
Arthritis Rheumatol; 2016 Jul; 68(7):1780-7. PubMed ID: 26815845
[TBL] [Abstract][Full Text] [Related]
31. A novel bispecific DARPin targeting FcγRIIB and FcεRI-bound IgE inhibits allergic responses.
Zellweger F; Gasser P; Brigger D; Buschor P; Vogel M; Eggel A
Allergy; 2017 Aug; 72(8):1174-1183. PubMed ID: 27997998
[TBL] [Abstract][Full Text] [Related]
32. Absence of Fc epsilonRI alpha chain results in upregulation of Fc gammaRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between Fc epsilonRI and Fc gammaRIII for limiting amounts of FcR beta and gamma chains.
Dombrowicz D; Flamand V; Miyajima I; Ravetch JV; Galli SJ; Kinet JP
J Clin Invest; 1997 Mar; 99(5):915-25. PubMed ID: 9062349
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of FcγR-mediated phagocytosis by IVIg is independent of IgG-Fc sialylation and FcγRIIb in human macrophages.
Nagelkerke SQ; Dekkers G; Kustiawan I; van de Bovenkamp FS; Geissler J; Plomp R; Wuhrer M; Vidarsson G; Rispens T; van den Berg TK; Kuijpers TW
Blood; 2014 Dec; 124(25):3709-18. PubMed ID: 25352126
[TBL] [Abstract][Full Text] [Related]
34. An immunoglobulin E-reactive chimeric human immunoglobulin G1 anti-idiotype inhibits basophil degranulation through cross-linking of FcepsilonRI with FcgammaRIIb.
Wigginton SJ; Furtado PB; Armour KL; Clark MR; Robins A; Emara M; Ghaemmaghami AM; Sewell HF; Shakib F
Clin Exp Allergy; 2008 Feb; 38(2):313-9. PubMed ID: 18070161
[TBL] [Abstract][Full Text] [Related]
35. In vivo depletion of CD4+FOXP3+ Treg cells by the PC61 anti-CD25 monoclonal antibody is mediated by FcgammaRIII+ phagocytes.
Setiady YY; Coccia JA; Park PU
Eur J Immunol; 2010 Mar; 40(3):780-6. PubMed ID: 20039297
[TBL] [Abstract][Full Text] [Related]
36. Immunotherapy targeting inhibitory Fcγ receptor IIB (CD32b) in the mouse is limited by monoclonal antibody consumption and receptor internalization.
Williams EL; Tutt AL; Beers SA; French RR; Chan CH; Cox KL; Roghanian A; Penfold CA; Butts CL; Boross P; Verbeek JS; Cragg MS; Glennie MJ
J Immunol; 2013 Oct; 191(8):4130-40. PubMed ID: 24026082
[TBL] [Abstract][Full Text] [Related]
37. IgG and IgE collaboratively accelerate expulsion of Strongyloides venezuelensis in a primary infection.
Matsumoto M; Sasaki Y; Yasuda K; Takai T; Muramatsu M; Yoshimoto T; Nakanishi K
Infect Immun; 2013 Jul; 81(7):2518-27. PubMed ID: 23630966
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets.
Clynes RA; Towers TL; Presta LG; Ravetch JV
Nat Med; 2000 Apr; 6(4):443-6. PubMed ID: 10742152
[TBL] [Abstract][Full Text] [Related]
39. The anti-IgE mAb omalizumab induces adverse reactions by engaging Fcγ receptors.
Balbino B; Herviou P; Godon O; Stackowicz J; Goff OR; Iannascoli B; Sterlin D; Brûlé S; Millot GA; Harris FM; Voronina VA; Nadeau KC; Macdonald LE; Murphy AJ; Bruhns P; Reber LL
J Clin Invest; 2020 Mar; 130(3):1330-1335. PubMed ID: 31770111
[TBL] [Abstract][Full Text] [Related]
40. IgG-Mediated Immune Suppression to Erythrocytes by Polyclonal Antibodies Can Occur in the Absence of Activating or Inhibitory Fcγ Receptors in a Full Mouse Model.
Bernardo L; Yu H; Amash A; Zimring JC; Lazarus AH
J Immunol; 2015 Sep; 195(5):2224-30. PubMed ID: 26188060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
